Hydrokortisoni Tiofarma

Hydrocortisone, the active ingredient in Hydrokortisoni Tiofarma, is a corticosteroid presented as an oral formulation for oral use. It is employed to replace deficient cortisol in adrenal insufficiency and to reduce inflammation in various autoimmune and inflammatory disorders.

GNH USA supplies Hydrokortisoni Tiofarma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU GMP standards and provides reliable logistics for global distribution.

Hydrocortisone acts on the glucocorticoid pathway to modulate inflammation and replace cortisol.

- Adrenal insufficiency: restores physiologic cortisol levels and prevents adrenal crisis. - Congenital adrenal hyperplasia: suppresses excess androgen production and supports normal growth. - Rheumatoid arthritis: reduces joint inflammation and pain, improving mobility. - Severe allergic dermatitis: diminishes skin inflammation and pruritus.

Hydrocortisone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Increased appetite and weight gain. - Fluid retention and mild edema. - Elevated blood glucose levels. - Mood changes such as irritability or euphoria. - Insomnia or difficulty sleeping. - Gastro‑intestinal discomfort.

Serious or Rare Side Effects: - Adrenal suppression leading to crisis on abrupt withdrawal. - Severe infections due to immunosuppression. - Cushingoid appearance with facial rounding and striae. - Osteoporosis and increased fracture risk. - Peptic ulcer disease or gastrointestinal bleeding. - Psychosis or severe mood disorders.

When prescribing hydrocortisone, clinicians should consider several safety measures.

- Assess adrenal function: evaluate baseline cortisol before initiating therapy. - Monitor blood glucose: adjust antidiabetic treatment as needed. - Use the lowest effective dose: limit duration to reduce systemic exposure. - Avoid abrupt discontinuation: taper gradually to prevent adrenal crisis. - Caution in active infection: evaluate risk‑benefit before use. - Store at ambient temperature: keep in the original pack, protect from moisture.

Hydrocortisone can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase glucocorticoid levels. - Anticoagulants (e.g., warfarin): enhanced anticoagulant effect, risk of bleeding. - NSAIDs: additive risk of gastrointestinal ulceration and bleeding.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): may reduce hydrocortisone exposure. - Antidiabetic agents: possible need for dose adjustment due to hyperglycaemia. - ACE inhibitors or ARBs: monitor for sodium retention and hypertension.